Author(s):
Neetu, Shailendra Kumar, Anshika Garg
Email(s):
anshikacreations03@gmail.com
DOI:
10.52711/2321-5836.2025.00017 
Address:
Neetu1, Shailendra Kumar2, Anshika Garg3
1R.V. Northland Institute, Dadri, Greater Noida, Uttar Pradesh, India.
2JMS Pharmacy College, Ghaziabad, Uttar Pradesh, India.
3Sanskar College of Pharmacy and Research, Ghaziabad, 201302, Uttar Pradesh, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 2,
Year - 2025
ABSTRACT:
For patients suffering from end-stage renal disease (ESRD) and chronic kidney disease (CKD), cardiovascular disease (CVD) is a major source of morbidity and mortality. This population's CV risk is greatly increased by the interaction of non-traditional risk factors like inflammation, oxidative stress, and aberrant calcium-phosphate levels with classic risk factors like diabetes, hypertension, and dyslipidemia. Early detection and care are crucial since the prevalence of CV problems increases significantly as CKD advances to ESRD. Results have frequently been less than ideal despite efforts to reduce CV risk using standard therapies and dialysis techniques, especially because of the intricate relationships that exist between traditional risk factors and malnutrition in CKD patients. Nutritional control, especially with renal diets, is essential for controlling CV risk factors since it treats proteinuria, insulin resistance, anemia, hypertension, and dyslipidemia. Certain dietary strategies, such as the high-protein, high-phosphorus keto diet, have demonstrated potential to improve CV outcomes by postponing the start of dialysis and maintaining residual renal function.
Cite this article:
Neetu, Shailendra Kumar, Anshika Garg. Interplay between Renal Dysfunction and Cardiovascular Complications: A Focus on Myocardial Infarction and Dietary Approaches. Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):107-1. doi: 10.52711/2321-5836.2025.00017
Cite(Electronic):
Neetu, Shailendra Kumar, Anshika Garg. Interplay between Renal Dysfunction and Cardiovascular Complications: A Focus on Myocardial Infarction and Dietary Approaches. Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):107-1. doi: 10.52711/2321-5836.2025.00017 Available on: https://rjppd.org/AbstractView.aspx?PID=2025-17-2-4
REFERENCES:
1. Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? Journal of the American College of Cardiology. 2006 Jan 3; 47(1):1-8.
2. Gottlieb S. Study quantifies dangers of renal disease after heart attack. BMJ. 2004 Sep 23; 329(7468): 702.
3. Davenport MS, Perazella MA, Nallamothu BK. Contrast-induced acute kidney injury and cardiovascular imaging: danger or distraction? Circulation. 2023 Mar 14; 147(11): 847-9.
4. Locatelli F, Bommer J, London GM, Martín‐Malo A, Wanner C, Yaqoob M, Zoccali C. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrology Dialysis Transplantation. 2001 Mar 1; 16(3):459-68.
5. Foley RN. Clinical epidemiology of cardiovascular disease in chronic kidney disease. Journal of renal care. 2010 May; 36:4-8.
6. S. Raghavi, V.G. Karthigeyan, S. Prabhu. Protective Effect of Plectranthus amboinicus Leaf Extract Containing Luteolin Flavanoid in Isoproterenol Hydrochloride Induced Myocardial Infarction in Rats - An Assessment on Biochemical and Cellular Changes. Research J. Engineering and Tech. 2013; 4(4): 195-198.
7. Saiprasanna Behera, S. Manohar Babu, Y Roja Ramani, Prasanta Kumar Choudhury, Rajeshree Panigrahi. Cardioprotective Activity of Ocimum canum Hydro-alcoholic Leaf Extracts Against Isoproterenol Induced Myocardial Infarction in Rats. Research J. Pharmacology and Pharmacodynamics. 2012; 4(4): 191-201.
8. Preeti Tiwari, Rakesh K Patel. Cardioprotective activity of Ashwagandharishta on Isoproterenol Induced Myocardial Infarction. Research J. Pharmacology and Pharmacodynamics. 2012; 4(5): 294-298.
9. Preeti Tiwari. Cardioprotective Activity of Amritarishta on Isoproterenol Induced Myocardial Infarction. Research J. Pharmacology and Pharmacodynamics. 2013; 5(6): 356-361.
10. S. Renuka, Gowri Sethu. Regeneration after Myocardial Infarction. Research J. Pharm. and Tech. 2015; 8(6): 738-741.
11. Hardik Joshi, Manoj Pagare, Leena Patil, Vilasrao Kadam. Cardioprotective Effect of Ethanolic Extract of Buchanania lanzan Spreng. Against Isoproterenol Induced Myocardial Infarction in Rats: A Biochemical, Electrocardiographic Evaluation. Research J. Pharm. and Tech. 2012; 5(2): 263-266.
12. S. Sarumathy, T. S. Shanmugarajan, K. G. Suresh Rao, N. Benazeer Begum. Significance of Clinical Laboratory Values as early indicators of Myocardial Infarction - A Retrospective Study. Research J. Pharm. and Tech. 2018; 11(4): 1563-1565.
13. Hasitha Diana Manohar, Srinivasan D, Sengottuvelu S. Cardioprotective activity of Limonia acidissima against Isoproterenol Induced Myocardial Infarction in Rats. Research J. Pharm. and Tech. 2016; 9(5): 541-544.
14. Gulnara Bedelbayeva, Zhannat Nurmakhanova, Murat Almukhambetov, Nazima Zarubekova, Ainur Nuftieva. Factors of the Complicated Course of the Myocardial Infarction in Men and Women. Research J. Pharm. and Tech. 2018; 11(5): 1737-1744.
15. J. S. Karnewar, V. K. Shandilya. Myocardial Infarction Detection using Morphological Features of ECG Signal. Research Journal of Pharmacy and Technology. 2023; 16(6):2921-6.
16. Sörnmo L, Laguna P. Electrocardiogram (ECG) signal processing. Wiley encyclopedia of biomedical engineering. 2006 Apr 14.
17. Shen L, Shah BR, Nam A, Holmes D, Alexander KP, Bhatt DL, Ho PM, Peterson ED, He B, Roe MT. Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction. American Heart Journal. 2014 Jun 1; 167(6): 840-5.
18. Valensi P, Lorgis L, Cottin Y. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Archives of Cardiovascular Diseases. 2011 Mar 1; 104(3): 178-88.
19. Cupisti A, Aparicio M, Barsotti G. Potential benefits of renal diets on cardiovascular risk factors in chronic kidney disease patients. Renal Failure. 2007 Jan 1; 29(5): 529-34.
20. Vaskonen T. Dietary minerals and modification of cardiovascular risk factors. The Journal of Nutritional Biochemistry. 2003 Sep 1; 14(9): 492-506.
21. Appel LJ. The effects of dietary factors on blood pressure. Cardiology Clinics. 2017 May 1; 35(2): 197-212.
22. Ferraro PM, Bargagli M, Trinchieri A, Gambaro G. Risk of kidney stones: influence of dietary factors, dietary patterns, and vegetarian–vegan diets. Nutrients. 2020 Mar 15;12(3):779.
23. McCarron DA. Dietary sodium and cardiovascular and renal disease risk factors: dark horse or phantom entry? Nephrology Dialysis Transplantation. 2008 Jul 1; 23(7): 2133-7.